Novonesis AS (Novonesis AS) Margin of Safety % (DCF Earnings Based) : -138.70% (As of Apr. 27, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2024-04-27), Novonesis AS's Predictability Rank is 4.5-Stars. Novonesis AS's intrinsic value calculated from the Discounted Earnings model is $23.36 and current share price is $55.76. Consequently,

Novonesis AS's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is -138.70%.

Competitive Comparison of Novonesis AS's Margin of Safety % (DCF Earnings Based)

For the Specialty Chemicals subindustry, Novonesis AS's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novonesis AS's Margin of Safety % (DCF Earnings Based) Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis AS's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Novonesis AS's Margin of Safety % (DCF Earnings Based) falls into.

Novonesis AS Margin of Safety % (DCF Earnings Based) Calculation

Novonesis AS's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)	=	(Intrinsic Value: DCF (Earnings Based)	-	Current Price)	/	Intrinsic Value: DCF (Earnings Based)
	=	(23.36	-	55.76)	/	23.36
	=	-138.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

Novonesis AS Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis AS (Novonesis AS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Margin of Safety % (DCF Earnings Based)

Comparable Companies

Traded in Other Exchanges

NVZMF:USA NZYM:Mexico NZYMBc:UK 0Q4U:UK NZYM B:Denmark NZM2:Germany

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

Not Just Yogurt Anymore

By PRNewswire • 10-26-2023

Novozymes A/S's Dividend Analysis

By GuruFocus Research • 10-19-2023

Novozymes Named EPA Safer Choice Partner of the Year for Third Year in a Row

By PRNewswire • 10-03-2023

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso • 11-06-2019